# Vaxcyte, Inc.: Form 8-K, filed Mar 6, 2023

- Company: [Vaxcyte, Inc.](/companies/pcvx.md) (CIK 1649094)
- Form: 8-K
- Filed: 2023-03-06
- Accepted by EDGAR: Mar 6, 2023, 16:16 ET
- Period: 2023-02-28
- Accession: 0001193125-23-061401
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1649094/000119312523061401/d476717d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1649094/000119312523061401/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1649094/000119312523061401/d476717d8k.htm

Filed Mar 6, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-061401. Last ingested by Listed: Nov 6, 2026, 13:09 ET. No prices; not investment advice.